Influence of Individualized Nutritional Therapy Combined With Whole Body Electromyostimulation on Patients With Chronic Liver Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Liver Diseases
- Sponsor
- University of Erlangen-Nürnberg Medical School
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- Muscle mass of chronic liver patients
- Last Updated
- 7 years ago
Overview
Brief Summary
The purpose of this study is to explore the influence of an innovative combined therapy involving optimized protein-rich nutritional therapy and highly effective muscle training by personalized whole-body electromyostimulation (WB-EMS) exercise to improve muscle mass, strength and functionality, physical capacity, fatigue and quality of life of patients with chronic liver disease.
Detailed Description
In the course of chronic liver disease a systemic inflammatory reaction promotes mediators leading to a loss of appetite, as well as to metabolic and hormonal changes. Consequences hereof are a decreased food uptake, a deteriorated nutrient utilization and a loss of muscles, with or without fat loss leading to cachexia. Especially muscle loss has a relevant influence on morbidity and mortality of chronic liver patients. The loss of muscle is probably due to a deteriorated protein synthesis with concurrent anabolic resistance. These pathologic processes increase the protein requirements of chronic liver patients dramatically. The purpose of this study is to establish an innovative combined therapy involving optimized nutritional therapy and highly effective muscle training by personalized whole-body electromyostimulation (WB-EMS) exercise to improve the quality of life (QLQ) of patients with serious chronic disease. An improvement of QLQ results from an increase in muscle mass and strength, thereby increasing physical activity, physical capability as well as tolerance to and applicability of therapy. In the course of a 3-months intervention study the efficacy of a combined German-guidelines-recommended protein-rich nutritional therapy with an innovative exercise therapy will be documented for patients with chronic liver disease. An effective stopping of the progress of muscle wasting or even increase of muscle mass, strength and function in the patients of the trial would benefit each patient and his family individually, since it could mean a considerable improvement in his QLQ and tolerability of therapeutical treatment.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with chronic liver disease in curative or palliative treatment
Exclusion Criteria
- •Healthy persons or patients under age
- •Pregnancy, Lactation,
- •Psychological disorders, epilepsy, sever neurological disorders
- •Participation in other exercise- or nutrition studies within the last 6 months
- •acute cardiovascular disease
- •Intake of anabolic drugs,
- •Skin injuries in the area of electrode placements
- •Electronic implants (defibrillator, pacemaker)
- •Persons in mental hospitals by order of authorities or jurisdiction
Outcomes
Primary Outcomes
Muscle mass of chronic liver patients
Time Frame: 3 months
Increase or stabilization of muscle mass of chronic liver patients due to combinatorial therapy of protein-rich nutrition and WB-EMS. Muscle mass will be measured by Bioelectrical Impedance Analysis.
Muscle strength of chronic liver patients.
Time Frame: 3 months
Increase or stabilization of muscle strength of chronic liver patients due to combinatorial therapy of protein-rich nutrition and WB-EMS. Muscle strength will be measured by hand grip strength measurements.
Secondary Outcomes
- Pain score as assessed by visual analogue score(3 months)
- Fatigue score as assessed by FACIT-Fatigue-Score analysis(3 months)
- Quality of life score as assessed by EORTC-QLQ-C30(3 months)
- Degree of toxicity of chemotherapy regarding gastrointestinal complaints as assessed by Common Toxicity Criteria (CTC)(3 months)